Holen Sie sich die Stockscreener-App
15.17
2.57%
0.38
Handel nachbörslich:
15.17
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
AngioDynamics Inc (ANGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AngioDynamics, Inc. Revenue Breakdown – NASDAQ:ANGO - TradingView
AngioDynamics Inc. (ANGO) SVP receives 8,047 shares, 4,506 withheld for tax - Stock Titan
AngioDynamics (NASDAQ: ANGO) executive settles 20,052 performance units - Stock Titan
AngioDynamics (NASDAQ: ANGO) CEO settles performance share grant - Stock Titan
AngioDynamics Inc (ANGO) CFO performance shares vest, tax withheld - Stock Titan
AngioDynamics (ANGO) SVP receives shares from PSU vesting, with tax withholding - Stock Titan
ANGO|AngioDynamics Inc|Price:13.825|Chg%:+0.235 - TradingKey
Form 4 AngioDynamics Inc For: 22 July By Investing.com - Investing.com Canada
AngioDynamics (ANGO) director receives 11,887-share stock award - Stock Titan
AngioDynamics Inc. (ANGO) awards 17,966 RSUs and performance rights - Stock Titan
ETFs Investing in AngioDynamics, Inc. Stocks - TradingView
AngioDynamics (ANGO) SVP uses 8,228 shares to cover RSU tax obligations - Stock Titan
AngioDynamics (ANGO) CFO withholds 12,067 shares to satisfy RSU tax obligations - Stock Titan
AngioDynamics (ANGO) SVP covers tax obligations through share withholding - Stock Titan
AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In - Seeking Alpha
AngioDynamics: Growth Is Working, Price Knows It (Rating Downgrade) - Seeking Alpha
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands - TradingView
AngioDynamics (NASDAQ: ANGO) details device portfolio and risk factors - Stock Titan
ANGIODYNAMICS INC FY 2026: Revenue $320.17M, EPS ($0.88) — 10-K Summary - TradingView
Is AngioDynamics Inc (ANGO) Overvalued After Q4 Earnings Miss? E - GuruFocus
AngioDynamics Inc reports results for the quarter ended May 31Earnings Summary - TradingView
AngioDynamics, Inc. 2026 Q4ResultsEarnings Call Presentation (NASDAQ:ANGO) 2026-07-14 - Seeking Alpha
AngioDynamics Releases Q4 2026 Financial Results - AlphaStreet
Record 2026 sales as AngioDynamics (NASDAQ: ANGO) grows Med Tech 18% - Stock Titan
AngioDynamics: Fiscal Q4 Earnings Snapshot - KVUE
AngioDynamics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Enterprise value to revenue forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to earnings forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Enterprise value to EBIT forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
ANGOAngiodynamic Inc Latest SEC Filings - Finviz
Price to sales forward of AngioDynamics, Inc. – NASDAQ:ANGO - TradingView
Price to sales forward of AngioDynamics, Inc. – LS:A0B9A5 - TradingView
Press Release: AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 - Moomoo
AngioDynamics sets July 14 call for fiscal 2026 results - Stock Titan
AngioDynamics, Inc.(NasdaqGS: ANGO) added to Russell 2000 Value-Defensive Index - marketscreener.com
AngioDynamics, Inc. Actuals & Estimates (NASDAQ:ANGO) - TradingView
ANGO Forecast — Price Target — Prediction for 2027 - TradingView
AngioDynamics Inc. (ANGO) Rises 5.25%: Support and Resistance Levels in FocusInitial Balance - dars.gov.et
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - TradingView
AngioDynamics Inc (ANGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
AngioDynamics Inc (ANGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AngioDynamics wins FDA okay to test NanoKnife in BPH patients - Stock Titan
AngioDynamics Inc (ANGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AngioDynamics Inc (ANGO) Institutional Confidence - TradingKey
AngioDynamics Inc (ANGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AngioDynamics, Inc. (ANGO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026Slideshow - Seeking Alpha
ANGO News | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury - AboutLawsuits.com
ANGO Technical Analysis & Stock Price Forecast - Intellectia AI
ANGO Stock Price, Quote & Chart | ANGIODYNAMICS INC (NASDAQ:ANGO) - ChartMill
Webcast set for AngioDynamics talk at Goldman Sachs health event - Stock Titan
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Yahoo Finance
Point72 (ANGO) reports 3.18M shares, 7.7% stake via Point72 Associates - Stock Titan
Prostate cancer trial sees 0 new failures with NanoKnife at 2 years - Stock Titan
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet - Yahoo Finance
AngioDynamics alleges patent infringement by E2 over clot removal technology - MassDevice
[8-K] ANGIODYNAMICS INC Reports Material Event - Stock Titan
Fair Value Assessment | AngioDynamics Inc. posts 117.8% EPS surprise beating loss estimatesEarnings Risk - Cổng thông tin điện tử tỉnh Tây Ninh
AngioDynamics files patent lawsuit against Endovascular Engineering - Investing.com
ANGO (AngioDynamics Inc.) notches massive Q1 2026 EPS beat, but shares fall 1.24 percent on slight year over year revenue decline.Social Trade Signals - Xã Thanh Hà
AngioDynamics (ANGO) Upgraded to Buy: Here's Why - Yahoo Finance
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down - TradingView
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):